Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00313599
First received: April 11, 2006
Last updated: July 1, 2014
Last verified: July 2014